Anna Blöchinger

[Anna Blöchinger @AnnaBlochinger]

@bakhti_mostafa @pacotael @LickertHeiko @ozumsehnaz @NatalieKrahmer @AimeeBastidas @Diana61204366 @LamaSaber95 Very interesting findings. Congratulations Mostafa, Perla and team :)

[Anna Blöchinger @AnnaBlochinger]

@ninahuber21 @Meier_Lab @PioneerCampus @LabWolfrum @johwirth @KokotekDaniel @JuliusPerschel @tschwarzromond @HelmholtzMunich Congratulations Nina, well deserved!

[Anna Blöchinger @AnnaBlochinger]

@aman_ansar Oh what a pity, we couldn't catch up :/

[Anna Blöchinger @AnnaBlochinger]

@LickertHeiko Congratulations Heiko and of course also to the whole IDR!

[Jeffrey Millman @JeffreyRMillman]

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments https://t.co/7dbv6SGeML via @statnews

[tagesschau @tagesschau]

Anmelderekord beim Europäischen Patentamt https://t.co/7KJYtExaCG #EuropäischesPatentamt #Patent #Huawei #Samsung #LGBT #Siemens #Bosch

[Anna Blöchinger @AnnaBlochinger]

Congratulations Thorsten and team :)

[Johanna Siehler @JohannaSiehler]

Congrats, @ThorstenKalten1 🥳🥂

[Mostafa Bakhti @bakhti_mostafa]

Looking for some major findings in Islet Biology in 2021? Here is our summary @NatureRevEndo. @LickertHeiko
https://t.co/NcFOYRLfjE
https://t.co/U1Ce76D2qV

[Mostafa Bakhti @bakhti_mostafa]

Our latest work on identification of Synaptotagmin-13 as a Neuroendocrine Marker, led by @MartaTarquis and in collaboration with @IsmaelGlezGcia and @CGarciaCaceres. Thanks to everybody involved. https://t.co/3vcI5K6Rnv #mdpiijms via @IJMS_MDPI

[Anna Blöchinger @AnnaBlochinger]

@bakhti_mostafa @MartaTarquis @IsmaelGlezGcia @CGarciaCaceres @IJMS_MDPI Congratulations to all of you 🎉

[PioneerCampus @HelmholtzMunich @PioneerCampus]

Rewarding to see cutting-edge work of your very own institution on the front page of Germany's Ministry for education and research 👏🎉🥂 @BMBF_Bund
Thank you for such recognition @Meier_Lab @LickertHeiko @helmholtz_diabc @helmholtz_de
https://t.co/ORfn59lUEo

[Anna Blöchinger @AnnaBlochinger]

Very happy to share that the second project of my PhD studies in the lab of @LickertHeiko is published in @LabonaChip 🎉Many thanks to my collaborators, especially to Jessi, Scott and Matthias from @Meier_Lab It was a pleasure working with you!

[Anna Blöchinger @AnnaBlochinger]

@kathischeibner @DGZ_2021 @LickertHeiko Congrats and very well deserved, Kathi!

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in engineering islets to provide therapies for diabetes, here's a comprehensive recent review by @LickertHeiko and colleagues https://t.co/EbjAjxhjBg

[Mostafa Bakhti @bakhti_mostafa]

A great study from our institute on intestinal stem cells. Congrats @tritschler_so @AnikaBoettcher @LickertHeiko @fabian_theis and the others involved.

[katharina scheibner @kathischeibner]

Looking for a #PhD position in #diabetes and #stemcell research in an outstanding scientific and international environment?

Then apply now for our project that aims to generate stem cell-derived islet-like clusters for beta cell replacement therapy.
https://t.co/AhWDqQCNAV

[PioneerCampus @HelmholtzMunich @PioneerCampus]

Most comprehensive 'state of affairs' in #engineering islets from #stemcells for #diabetes therapies👍
Crafted by @helmholtz_diabc @PioneerCampus experts https://t.co/rKHAuZmnoi HOPE YOU ENJOY 📃 🧬🔬🩺✅
@NatRevDrugDisc

[Deutsches Zentrum für Diabetesforschung (DZD) @DiabResearch]

Interested in "Engineering islets from stem cells for advanced therapies of diabetes"? Then read the review article from @LickertHeiko, @JohannaSiehler
, @AnnaBlochinger and Matthias Meier in
Nature Reviews Drug Discovery. 📰
https://t.co/PRU6HNymri
▶️https://t.co/5fThhfa39g

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Engineering islets from stem cells for advanced therapies of diabetes https://t.co/fiIek60YDW - a new review by @JohannaSiehler , @AnnaBlochinger , Matthias Meier and @LickertHeiko

[PioneerCampus @HelmholtzMunich @PioneerCampus]

Highlight of an extremely productive cooperation towards pancreatic beta-cell replacement by @PioneerCampus PI Mathias Meier @helmholtz_diabc @LickertHeiko #engineering empowered future #therapies @NatRevDrugDisc
https://t.co/NgezsqbpA1